So we know that many European countries rely heavily on private insurance or mandated private insurance to meet the cost in whole or in part of pharmaceuticals. When Pharmac agrees to fund a drug, they agree to fund it 100 percent. The cost to the consumer is the prescription charge of $5 each time, up to an annual value of $100. But that's what sets New Zealand apart from pretty much every other country—that when we agree to fund a pharmaceutical, then we agree to fund it 100 percent. In most other countries it's at best a partial funding.